A carregar...
Development of encorafenib for BRAF-mutated advanced melanoma
PURPOSE OF REVIEW: To describe the pharmacological properties, preclinical and clinical data of the novel V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF)-inhibitor encorafenib (LGX818) and to compare these with established BRAF-inhibitors in the treatment of locally advanced or metastatic melan...
Na minha lista:
| Publicado no: | Curr Opin Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5815646/ https://ncbi.nlm.nih.gov/pubmed/29356698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000426 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|